Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02238496
Title Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Andrew Lassman
Indications

glioblastoma

malignant astrocytoma

oligodendroglioma

high grade glioma

gliosarcoma

mixed glioma

Therapies

Perifosine + Temsirolimus

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Columbia University Medical Center New York New York 10032 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field